Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study
-
Published:2021-09
Issue:
Volume:155
Page:73-84
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Antoniotti Carlotta, Korn W. Michael, Marmorino Federica, Rossini Daniele, Lonardi SaraORCID, Masi GianlucaORCID, Randon Giovanni, Conca VeronicaORCID, Boccaccino AlessandraORCID, Tomasello Gianluca, Passardi Alessandro, Swensen Jeff, Ugolini ClaraORCID, Oberley MatthewORCID, Tamburini EmilianoORCID, Casagrande Mariaelena, Domenyuk Valeriy, Fontanini Gabriella, Giordano Mirella, Abraham JimORCID, Spetzler David, Falcone Alfredo, Lenz Heinz-Josef, Cremolini Chiara
Subject
Cancer Research,Oncology
Reference47 articles.
1. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer;Douillard;N Engl J Med,2013 2. Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer;Van Cutsem;J Clin Oncol,2015 3. Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies;Venderbosch;Clin Cancer Res,2014 4. Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis;Pietrantonio;Eur J Cancer,2015 5. Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E-mutant metastatic colorectal cancer: updated survival results and subgroup Analyses from the BEACON study;Tabernero;J Clin Oncol,2021
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|